Home/Filings/4/0000950170-25-099793
4//SEC Filing

Kim Paul 4

Accession 0000950170-25-099793

CIK 0001674930other

Filed

Jul 28, 8:00 PM ET

Accepted

Jul 29, 6:04 PM ET

Size

5.1 KB

Accession

0000950170-25-099793

Insider Transaction Report

Form 4
Period: 2025-07-26
KIM PAUL
CFO and Treasurer
Transactions
  • Tax Payment

    Common Stock

    2025-07-26$18.37/sh2,743$50,389339,828 total
Footnotes (1)
  • [F1]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.

Documents

1 file

Issuer

Fulgent Genetics, Inc.

CIK 0001674930

Entity typeother

Related Parties

1
  • filerCIK 0001253820

Filing Metadata

Form type
4
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 6:04 PM ET
Size
5.1 KB